“More and more people are trading options. Ordinary investors just like you. Back on September 8th I interviewed the CEO of OptionsXpress, OXPS. With the stock at $16.94. Now after reporting a genuine up side surprise...
Read More“Check out Gilead. Profit up 36% from a year ago. Well ahead of expectations at 78 cents [non-GAAP] versus a 67 estimate. The revenues grew 31% from a year ago. Product sales strong, royalties strong, but the stock is...
Read MoreMedical device maker Boston Scientific (BSX) reported third quarter earnings which showed the company swung back to a profit. Net income came in at $200 million or 12 cents per share after backing out one-time charges,...
Read MoreWe want a stock like Itron. The dominant player in smart grid; which is the smart grid transformation. When some huge, moldy company talks about how great the smart grid is like GE did Friday and IBM did on Thursday, you go take...
Read MoreAccording to Bose George analyst at Keefe, Bruyette & Woods, the two government sponsored entities that buy mortgages from banks have zero value to common shareholders. KBW downgraded the shares to Underperform and...
Read More“BB&T bank out with its earnings, came out with $0.23 a share, a penny better than Thomson was looking for. Also talked about revenue of $2.8 billion in line…. Looking for non-performing assets as a percentage...
Read MoreThe price-to-peak earnings multiple has increased to 12.2x as of the close of last week’s trading. The S&P 500 index advanced about 1.5% in the last week, as earnings reports were largely better than expected...
Read MoreThe largest deal among drug makers in the last year was completed today as Pfizer (PFE) officially merged with Wyeth (WYE). At the close of trading on Thursday, Wyeth was delisted from the NYSE. Pfizer has wasted no...
Read More“We call it FLIR, for all of you home gamers. Now FLIR gets about 53% of its sales from its government systems division. The selling products that are used for surveillance, protecting strategic assets, drug enforcement,...
Read MoreAs market watchers are well aware, Goldman Sachs (GS) cruised to a solid profit in the third quarter of $3.19 billion or $5.25 per share. Goldman tripled their earnings of last year, and handily beat consensus...
Read More
